Applications of Stable Nuclide and Radionuclides in the Area of Pharmacokinetic Process Control and Targeted Drug Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 189
Special Issue Editors
Interests: immunology
Interests: biokinetics; dispersed systems; analytical chemistry; environmental pollution
Special Issues, Collections and Topics in MDPI journals
Interests: kinetic isotope effect; nanoparticle drugs; supramolecular complexes; laser diffraction spectroscopy; dissolution rate; validation studies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Technologies related to the use of stable and radioactive isotopes are becoming increasingly important for elucidating the mechanism of pathogenesis, diagnosis of disease, management of pharmacokinetic processes, therapy of diseases with aggressive clinical courses, properties of drug molecules, and the search for novel drugs. Innovative isotope technologies have been developed by nuclear chemists, microbiologists, engineers, and a wide range of scientists and medical professionals; they have since been approved by the FDA and the Center for Drug Evaluation and Research (CDER). Herein, a current list of FDA-approved radiopharmaceuticals is provided.
We are pleased to invite submissions to a new Special Issue of Pharmaceutics dedicated to the application of isotopes in pharmacy. This Special Issue aims to cover current research on isotope technologies in pharmaceutical use.
We encourage the submission of original research articles and reviews to this Special Issue. Research areas may include (but are not limited to) the following: isotope-modified drug substances and dissolution media; isotope control of pharmacokinetics; isotope diagnostics with radiopharmaceuticals; isotopologues for pharmacy; methods for the study of media containing isotopes; and isotope-containing adjuvants.
We are looking forward to receiving your contributions
Prof. Dr. Roman Zubarev
Prof. Dr. Anton V. Syroeshkin
Dr. Elena Uspenskaya
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- • stable nuclide
• radionuclides
• isotopologues
• deuterated drugs
• pharmacokinetics
• radiopharmaceuticals
• deuterium depleted water
• heavy water
• isotope analysis
• isotope ratio
